Laboratory Findings in Systemic Lupus Erythematosus
The correct statements are c) and e): hemolytic anemia frequently occurs during active SLE, and prolonged partial thromboplastin time suggests coexistence of antiphospholipid syndrome.
Analysis of Each Statement
a) Leukocytosis is the rule in SLE - INCORRECT
Leukocytosis is not characteristic of SLE. In fact, the opposite is true:
- Leukopenia and lymphopenia are common findings in active SLE 1
- Severe leucopenia and lymphopenia have been associated with increased risk of infections 1
- This is a key distinguishing feature from other inflammatory conditions where leukocytosis would be expected
b) C-reactive protein is a better indicator of disease activity than ESR - INCORRECT
This statement is fundamentally wrong:
- CRP is typically normal or only marginally elevated in SLE despite high disease activity 1
- The significance of CRP in SLE remains controversial, with patients rarely having elevated CRP levels 1
- When CRP is significantly elevated (>50 mg/L) along with clinical suspicion, a superimposed infection should be excluded 1
- ESR is more commonly elevated in active SLE and better reflects disease activity than CRP
Clinical pitfall: A significantly elevated CRP in an SLE patient should prompt investigation for infection rather than being interpreted as lupus activity alone.
c) Hemolytic anemia frequently occurs during the active phase - CORRECT
This is accurate:
- Severe anemia has been variably associated with organ involvement, disease progression, and worse prognosis 1
- Autoimmune hemolytic anemia is a recognized manifestation of active SLE
- The presence of RBC autoantibodies was found in 76% of SLE patients in diagnostic studies 2
d) Complement levels are high during the active phase - INCORRECT
This is the opposite of what occurs:
- Complement levels (C3 and C4) are typically LOW during active disease 3, 1
- Testing for complement levels should be considered in patients with suspected lupus nephritis 3
- Low complement reflects consumption due to immune complex formation and activation of the complement cascade
- Complement levels are sometimes associated with active disease, though no predictive value for disease flares has been consistently reported 1
e) Prolongation of partial thromboplastin time suggests coexistence of antiphospholipid syndrome - CORRECT
This is accurate and clinically important:
- Prolonged aPTT is a key finding in lupus anticoagulant (LA) testing, which is part of antiphospholipid syndrome diagnosis 4
- LA testing uses aPTT as one of the first-choice screening tests (along with dilute Russell's viper venom time) 4
- All patients with SLE, especially those with suspected kidney involvement, should be tested for antiphospholipid antibodies 3
- The presence of antiphospholipid antibodies occurs in 30-40% of SLE patients 5
- A prolonged aPTT requires confirmation through mixing and confirmatory studies to distinguish LA from other causes of prolongation 4
Clinical significance: Recognition of antiphospholipid syndrome in SLE patients is critical as it carries prognostic implications and affects management, particularly regarding thrombotic risk and pregnancy complications 3, 1.
Summary of Correct Laboratory Patterns in SLE
Typical findings include:
- Cytopenias (leukopenia, lymphopenia, thrombocytopenia) rather than leukocytosis
- Low complement levels (C3, C4) during active disease
- Normal or minimally elevated CRP despite high ESR
- Positive autoantibodies (ANA, anti-dsDNA)
- Hemolytic anemia in active disease
- Prolonged aPTT when antiphospholipid syndrome coexists